Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 5Phase NA 3Phase 3 2Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Leukemia 3Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Ependymoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Doxorubicin 25Ifosfamide 22Radiotherapy 17Etoposide 11Vincristine 10Cyclophosphamide 10Filgrastim 8Dactinomycin 8Trabectedin 7Chemotherapy, Adjuvant 5pazopanib 4Cisplatin 4Topotecan 3Radiation 3Neoadjuvant Therapy 3Irinotecan 3Granulocyte Colony-Stimulating Factor 3Dacarbazine 3sargramostim 2etoposide phosphate 2eribulin 2Observation 2Methotrexate 2Mesna 2Imatinib Mesylate 2Gemcitabine 2Epirubicin 2Docetaxel 2Dexrazoxane 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Sarcoma × Mesna × Clear all
NCT00002516 2013-09-17

Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00001300 2008-03-04

A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
150 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡